Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
← Obstetrics and gynaecology indexChapter sections
OverviewAetiologyPathophysiologyClinical features and red flagsInvestigationsDifferential diagnosisManagementComplicationsMonitoring and follow-upSpecial situationsCommon pitfallsQuestionsSources
Full textbook13 sectionsOpen only what you need
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.

Dermoid cyst, endometrioma and cystadenoma

Obstetrics and gynaecology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
A benign mass can still cause an emergency

Sudden severe pain, vomiting, peritonism, syncope or sepsis may indicate torsion, rupture, haemorrhage or infection involving a previously stable adnexal mass.

Action: Assess physiology and pregnancy status immediately, give analgesia, involve acute gynaecology and arrange urgent imaging or laparoscopy; do not wait for an elective endometriosis or cyst clinic appointment.

Overview

Differentiate three common persistent benign ovarian masses, connect imaging phenotype with symptoms and fertility priorities, and plan appropriate specialist surveillance or tissue-preserving surgery while respecting diagnostic uncertainty.

These lesions share persistence but differ biologically. A mature cystic teratoma is a benign germ-cell tumour containing variable fat, sebaceous material, hair, bone or teeth. An endometrioma is an ovarian manifestation of endometriosis, formed by repeated haemorrhage within ectopic endometrial tissue. A cystadenoma is an epithelial neoplasm, commonly serous or mucinous, that is usually benign but can overlap morphologically with borderline tumours. Imaging estimates probability; removed tissue provides the final diagnosis.

Clinical context sharpens interpretation. Dermoids are frequently incidental but can cause pressure or torsion as they enlarge. Endometriomas often accompany dysmenorrhoea, deep dyspareunia, cyclical bowel or urinary pain and subfertility, although symptoms do not correlate perfectly with lesion size. Cystadenomas may remain silent until abdominal enlargement, discomfort or urinary and bowel pressure develops. Ask about abrupt pain, reproductive plans, previous endometriosis surgery and family cancer history before discussing follow-up.

Practice

Two practice questions

Your practice draft is saved in this browser.

Question 1 of 2
0 correct
Obstetrics and gynaecologyOriginal SBA

Tumour markers in a young patient

A 32-year-old has a persistent complex ovarian mass with solid and cystic areas that is not a classic dermoid. Which additional marker approach is appropriate?

Choose one answer, then submit
← Rapid synopsisBack to overviewAll Obstetrics and gynaecology topics →
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • RCOG Green-top Guideline 62: Ovarian Masses in Premenopausal Women
  • NICE NG73: Endometriosis diagnosis and management recommendations
  • NHS: Ovarian cyst treatment
  • Leeds Teaching Hospitals: Laparoscopic ovarian cystectomy

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom

On ultrasound, dermoids can show a highly echogenic component with shadowing, echogenic lines and dots from hair, a fat-fluid level or a mural Rokitansky nodule. Endometriomas classically have homogeneous low-level echoes and little internal flow, sometimes with wall foci; a retracting haemorrhagic clot can mimic this pattern and interval resolution favours a functional cyst. Serous cystadenoma is commonly a smooth unilocular cyst, while a mucinous lesion is often multilocular with fluid of different echogenicity. Any papillary or vascular solid component changes risk assessment.

Tumour markers answer a risk question, not a histological one. CA125 may rise substantially in endometriosis and is not recommended to diagnose endometriosis. In a clearly typical endometrioma, referral should not be held up for a marker. A complex mass in a patient under 40 requires AFP, beta-hCG and LDH assessment under the premenopausal mass pathway because malignant germ-cell tumours occur in this age group. No normal marker panel can neutralise suspicious morphology.

Management of a dermoid balances symptoms, size, growth, torsion risk, age, ovarian reserve and diagnostic confidence. RCOG states that dermoids tend to grow and that surgery is often appropriate, but no evidence-based operative size threshold exists; published observation series have commonly limited inclusion to lesions around 50–60 mm. A small asymptomatic typical lesion can therefore be observed after informed discussion, while growth, symptoms or indeterminate features favour surgery.

Endometrioma decisions must integrate pain and fertility. NICE recommends specialist endometriosis referral and advises that endometriosis treatment follow symptoms, preferences and priorities rather than stage alone. If fertility is a priority and surgery is chosen, laparoscopic cystectomy with wall excision or drainage and ablation can improve spontaneous pregnancy; drainage and ablation may preserve more ovarian reserve, while excision can reduce recurrence. Bilateral disease, low reserve and repeat surgery make tissue loss especially important.

Cystadenomas do not regress like functional cysts. Persistent, enlarging or symptomatic lesions generally reach gynaecology for operative discussion, and very large masses may need a route that permits intact removal and adequate inspection. Cystectomy can preserve ovarian tissue in a premenopausal patient with reassuring features; oophorectomy may be safer when normal tissue cannot be separated, after menopause or when malignancy risk is greater. Consent must include the possible change in procedure if intra-operative findings are concerning.

Whenever surgery is performed, avoid uncontrolled spill where possible because benign appearance cannot absolutely exclude cancer. Use an experienced laparoscopic surgeon and a retrieval bag when appropriate. Dermoid content can provoke chemical peritonitis if not completely cleared, while rupturing a hidden malignant tumour can alter staging. Send the specimen for histopathology, review the result, and escalate an unexpected borderline or malignant diagnosis through the gynaecological-oncology multidisciplinary team.

Key points

  • A mature cystic teratoma, commonly called a dermoid, contains tissues from more than one germ layer; fat, hair, calcification and an echogenic mural nodule create its characteristic but not infallible imaging pattern.
  • An endometrioma forms from ectopic endometrial tissue within the ovary and often shows homogeneous low-level ground-glass echoes; symptoms and specialist imaging assess associated deep endometriosis.
  • Serous cystadenomas are often thin-walled and unilocular, whereas mucinous cystadenomas may become large and multilocular; neither label is definitive until histopathology.
  • Persistence distinguishes these masses from most functional cysts. Compare serial morphology and growth, but do not let apparently benign imaging override new pain, cancer symptoms or acute deterioration.
  • Refer suspected or confirmed endometrioma to a specialist endometriosis service under NICE guidance, particularly when pain, fertility or deep disease requires coordinated decisions.
  • There is no evidence-based dermoid diameter that automatically mandates surgery; RCOG notes that studies of observation commonly used an arbitrary 50–60 mm upper limit.
  • When endometrioma surgery is considered for fertility, discuss cystectomy versus drainage and ablation, spontaneous-pregnancy benefit, recurrence and potential loss of ovarian reserve.
  • For presumed benign surgery, laparoscopy is usually preferred when feasible, with ovarian cystectomy where appropriate and planned specimen containment to limit spillage.

Aetiology

01

Totipotent germ cells

Mature cystic teratomas arise from germ cells and differentiate into adult-type tissues derived from multiple embryological layers.

02

Ectopic endometrial tissue

Endometriomas develop when endometriotic tissue involves the ovary and undergoes repeated cyclical bleeding within a walled cavity.

03

Benign epithelial proliferation

Serous and mucinous cystadenomas arise from epithelial-type ovarian tumour pathways and expand as persistent fluid-filled neoplasms.

Pathophysiology

  1. 1
    Sebaceous accumulation

    Dermoid epithelium produces lipid-rich material and hair around a solid protuberance, generating fat, calcification and acoustic shadowing.

  2. 2
    Repeated ovarian haemorrhage

    Endometriotic implants bleed and incite inflammation, fibrosis and adhesions, while degraded blood creates homogeneous low-level internal echoes.

  3. 3
    Epithelial fluid secretion

    Cystadenoma lining secretes fluid into one or many compartments, allowing progressive enlargement without normal cycle-dependent involution.

  4. 4
    Mass-related mechanics

    Increasing ovarian volume creates pressure symptoms and mobility, raising torsion risk particularly for benign masses with limited adhesions.

Clinical features and red flags

Dermoid signature

Fat, calcification, acoustic shadowing, echogenic hair lines or a mural nodule strongly suggests mature cystic teratoma but still requires complete risk assessment.

Endometrioma signature

Persistent homogeneous ground-glass echoes with endometriosis symptoms support endometrioma, while new vascular solid tissue demands specialist reassessment.

Serous phenotype

A smooth thin-walled unilocular lesion can represent serous cystadenoma, but a simple appearance alone cannot guarantee histological subtype.

Mucinous phenotype

A large multilocular cyst with compartments of differing echogenicity suggests mucinous origin and requires careful exclusion of borderline change and gastrointestinal mimics.

Acute complication

New severe pain, vomiting, guarding, fever or collapse converts an elective benign-mass problem into urgent torsion, rupture, haemorrhage or infection assessment.

Red flags requiring action

  • Acute unilateral pain with vomiting in a patient with a dermoid or other ovarian mass is torsion until urgent assessment makes that diagnosis unlikely.
  • Ascites, irregular vascular solid tissue, papillary projections, peritoneal nodules or unexplained weight loss requires gynaecological-oncology triage rather than benign cyst surgery.
  • A rapidly enlarging or very large multilocular lesion can cause pressure, compromise imaging completeness and occasionally conceal a borderline or malignant process.
  • Fever, marked tenderness and inflammatory illness with a complex mass may represent tubo-ovarian abscess, including infection superimposed on endometriosis.
  • Bilateral endometriomas, previous ovarian surgery or a solitary functioning ovary raises the consequence of further tissue loss and warrants early fertility-aware planning.

Investigations

  1. 01
    Expert transvaginal ultrasoundFirst step
    Why
    Describe origin, dimensions, locules, wall, contents, acoustic shadows, papillary structures, solid tissue and vascularity.
    Interpretation and limitations
    A recognised benign pattern guides referral and planning, but indeterminate or malignant features require specialist ultrasound or oncology assessment.
  2. 02
    Transabdominal ultrasound
    Why
    Map the cranial extent and relationship of a large cystadenoma or mass that exceeds the transvaginal field.
    Interpretation and limitations
    Use it to complement detailed pelvic morphology and assess ascites, not as a lower-resolution substitute for transvaginal characterisation.
  3. 03
    Pregnancy test
    Why
    Identify pregnancy-related emergencies and adapt imaging, analgesia and timing of any operation.
    Interpretation and limitations
    A positive result with pain or bleeding requires ectopic assessment; a coexisting ovarian lesion does not explain away pregnancy risk.
  4. 04
    Age-directed tumour markers
    Why
    Support triage when a persistent complex lesion could represent epithelial or germ-cell malignancy.
    Interpretation and limitations
    Use CA125 according to morphology and pathway; in patients under 40 with a complex mass add AFP, beta-hCG and LDH, recognising normal results do not exclude cancer.
  5. 05
    Specialist ultrasound or pelvic MRI
    Why
    Resolve indeterminate morphology, map deep endometriosis or define a lesion too large for complete ultrasound assessment.
    Interpretation and limitations
    MRI can identify fat or blood products and map anatomy, but imaging remains probabilistic and does not replace histology when tissue diagnosis is required.
  6. 06
    Histopathological examination
    Why
    Establish mature teratoma, endometrioma, cystadenoma, borderline tumour or malignant subtype after removal.
    Interpretation and limitations
    The final result determines follow-up; unexpected borderline or malignant pathology requires prompt oncology review and possible completion staging.

Differential diagnosis

01

Haemorrhagic functional cyst

Reticular fibrin, retracting avascular clot and subsequent resolution favour acute luteal haemorrhage over a persistent endometrioma.

02

Borderline ovarian tumour

Papillary projections and complex epithelial architecture can overlap with cystadenoma, requiring oncology assessment and histological classification.

03

Tubo-ovarian abscess

A thick irregular complex collection with fever, inflammatory illness and pelvic tenderness may be infection rather than endometrioma.

04

Metastatic mucinous disease

Bilateral or atypical mucinous ovarian masses can originate from gastrointestinal sites and need specialist clinical, imaging and pathological correlation.

Management

01Typical dermoidBalance observation against growth and torsionFirst stepUltrasound suggests a mature cystic teratoma without acute symptoms or malignant features.+
  1. 1Assess maximum diameter, growth, pain, reproductive priorities, ovarian reserve context and confidence that the entire lesion was visualised.
  2. 2Explain that no evidence-based operative cutoff exists and agree surveillance or surgery through informed preference rather than an automatic number.
  3. 3If operating, favour tissue-preserving laparoscopy when suitable, use containment and clear any inadvertent sebaceous spill with thorough warm lavage.
02Suspected endometriomaConnect imaging to specialist endometriosis careA persistent ground-glass ovarian cyst or associated symptoms suggest an endometrioma.+
  1. 1Offer specialist referral, assess pain and deep-disease symptoms, and use specialist imaging when bowel, bladder or ureteric involvement is possible.
  2. 2Discuss medical symptom control when not trying to conceive and separate that decision from whether the ovarian lesion itself needs surgery.
  3. 3When fertility is prioritised, involve fertility expertise and compare cystectomy with drainage and ablation, including ovarian-reserve and recurrence trade-offs.
03Probable cystadenomaPlan removal without assuming benign histologyA persistent unilocular or multilocular epithelial-appearing lesion causes symptoms, enlarges or cannot be safely observed.+
  1. 1Complete morphology-based cancer triage and appropriate markers before assigning the case to benign gynaecology or oncology care.
  2. 2Choose laparoscopy, mini-laparotomy or laparotomy according to size, contents, extraction plan, patient factors and surgeon expertise.
  3. 3EscalationConsent for cystectomy, possible oophorectomy and escalation if suspicious disease is encountered, then ensure histology ownership.
04Unexpected riskStop benign surgery and protect stagingImaging, operative inspection or pathology raises concern for a borderline or malignant ovarian tumour.+
  1. 1Avoid further rupture or piecemeal extraction, document findings and obtain appropriate washings or biopsies only within the planned specialist approach.
  2. 2Seek gynaecological-oncology advice and use multidisciplinary review to determine staging, fertility-sparing eligibility and any further surgery.
  3. 3Explain diagnostic uncertainty and next steps promptly, including the implications of prior cyst rupture or incomplete staging.

Complications

01

Adnexal torsion

Dermoids and other mobile benign masses can rotate the ovarian pedicle, producing venous obstruction, ischaemia and potential loss of function.

02

Chemical peritonitis

Spilled sebaceous dermoid content rarely causes severe sterile peritoneal inflammation, so retrieval and copious warm lavage are important.

03

Reduced ovarian reserve

Endometrioma itself and repeated excisional surgery can reduce functioning ovarian tissue, especially with bilateral disease or difficult haemostasis.

04

Unexpected neoplasia

Borderline or malignant histology can be discovered after presumed benign surgery, potentially requiring specialist staging and further treatment.

Monitoring and follow-up

  • For observation, record the precise imaging diagnosis, size and interval rather than using a generic annual scan for every benign-appearing mass.
  • Track growth and new morphological features alongside pain, abdominal pressure and acute torsion symptoms; stable size alone is not complete review.
  • Consider outpatient follow-up with imaging for an endometrioma larger than 3 cm when surgery is not chosen, as NICE specifically highlights this group.
  • After cystectomy, review histology, symptom recovery and any need for endometriosis, oncology or fertility follow-up with named ownership.
  • In bilateral disease or after repeat ovarian surgery, reassess fertility priorities before another procedure and avoid using one AMH result as a guarantee of fecundity.

Special situations

Fat points toward teratoma

MRI or ultrasound identification of fat is highly informative for dermoid, whereas calcification alone is not a complete diagnosis.

Blood can mimic blood

A haemorrhagic corpus-luteum cyst may resemble an endometrioma; interval resolution and evolving clot appearance help distinguish them.

CA125 is not an endometriosis test

NICE advises against using CA125 to diagnose endometriosis because both normal and raised values can mislead clinical interpretation.

Dermoid thresholds are not absolute

The often-quoted 50–60 mm observation limit reflects study inclusion criteria rather than a validated boundary requiring surgery.

Histology can redirect the pathway

An apparently benign cystadenoma may prove borderline, making careful containment, documentation and postoperative result review essential.

Common pitfalls

  1. 01

    Calling an echogenic lesion a dermoid without documenting vascular solid tissue, shadowing and the complete ovarian morphology.

  2. 02

    Using CA125 to diagnose endometriosis or interpreting an endometriosis-related elevation as proof of ovarian cancer.

  3. 03

    Applying a rigid dermoid size threshold when symptoms, growth, fertility context and diagnostic confidence should determine management.

  4. 04

    Draining a cystadenoma without a durable plan, despite persistence, recurrence and the loss of histological architecture.

  5. 05

    Performing repeat bilateral endometrioma cystectomy without discussing cumulative ovarian tissue loss and alternatives with fertility expertise.

  6. 06

    Assuming preoperative benignity permits uncontrolled cyst rupture or removes the need to review final histopathology.